FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229072237> ?p ?o ?g. }

• W4229072237 endingPage "867" @default.
• W4229072237 startingPage "859" @default.
• W4229072237 abstract "Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammatory disease of the upper airways. AZD1981 is a selective antagonist of chemoattractant receptor-homologous molecule expressed on T helper type 2 and other type 2 cells, including innate lymphoid cells type 2, eosinophils, and basophils. Objective To evaluate the efficacy of AZD1981 in reducing nasal polyp size when added to intranasal corticosteroids in adult patients with CRSwNP. Methods Eighty-one subjects (18–70 years of age) with CRSwNP were recruited and screened for trial eligibility from allergy and otolaryngology clinics from a single tertiary care site between June 2016 and August 2019. Eligible patients were randomized in a double-blind fashion to receive either AZD1981 (n = 22) or placebo (n = 21) orally three times a day for 12 weeks, added to intranasal corticosteroids. The primary endpoint was a change in nasal polyp score (NPS) at 12 weeks. Secondary endpoints included improvement in sinus computed tomography using Lund Mackay scoring, symptoms using visual analog scale, quality of life using Sino Nasal Outcome Test-22, and the Brief Smell Identification Test. Results Forty-three patients met the inclusion criteria and were enrolled. At 12 weeks, there was no difference in NPS change in the AZD1981 arm (mean 0, standard error 0.34, n = 15) compared with placebo (mean 0.20, standard error 0.36, n = 17); mean difference −0.20 (95% confidence interval: −1.21, 0.81; p = .69). No significant differences were observed for Lund Mackay score, symptoms, quality of life, or smell test. AZD1981 was well tolerated except for one case of hypersensitivity reaction. Conclusion In patients with CRSwNP, the addition of AZD1981 to intranasal corticosteroids did not change nasal polyp size, radiographic scores, symptoms, or disease-specific quality of life." @default.
• W4229072237 created "2022-05-08" @default.
• W4229072237 creator A5006474475 @default.
• W4229072237 creator A5021824454 @default.
• W4229072237 creator A5028761825 @default.
• W4229072237 creator A5033535964 @default.
• W4229072237 creator A5045386706 @default.
• W4229072237 creator A5047671590 @default.
• W4229072237 creator A5051502371 @default.
• W4229072237 creator A5053008699 @default.
• W4229072237 creator A5053082544 @default.
• W4229072237 creator A5054391702 @default.
• W4229072237 creator A5056666751 @default.
• W4229072237 creator A5072499672 @default.
• W4229072237 creator A5081247269 @default.
• W4229072237 creator A5081598314 @default.
• W4229072237 creator A5083463868 @default.
• W4229072237 creator A5085628613 @default.
• W4229072237 date "2022-05-18" @default.
• W4229072237 modified "2023-10-17" @default.
• W4229072237 title "Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial" @default.
• W4229072237 cites W1516009098 @default.
• W4229072237 cites W1968876836 @default.
• W4229072237 cites W1982358898 @default.
• W4229072237 cites W1990234801 @default.
• W4229072237 cites W2002479665 @default.
• W4229072237 cites W2012646589 @default.
• W4229072237 cites W2019535648 @default.
• W4229072237 cites W2039439214 @default.
• W4229072237 cites W2080883768 @default.
• W4229072237 cites W2092078565 @default.
• W4229072237 cites W2158088730 @default.
• W4229072237 cites W2194674866 @default.
• W4229072237 cites W2412685330 @default.
• W4229072237 cites W2510774880 @default.
• W4229072237 cites W2515977513 @default.
• W4229072237 cites W2519161146 @default.
• W4229072237 cites W2611413896 @default.
• W4229072237 cites W2802493538 @default.
• W4229072237 cites W2898494075 @default.
• W4229072237 cites W2903906519 @default.
• W4229072237 cites W2946495325 @default.
• W4229072237 cites W3159402038 @default.
• W4229072237 cites W3183099619 @default.
• W4229072237 doi "https://doi.org/10.1111/cea.14158" @default.
• W4229072237 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35524339" @default.
• W4229072237 hasPublicationYear "2022" @default.
• W4229072237 type Work @default.
• W4229072237 citedByCount "6" @default.
• W4229072237 countsByYear W42290722372023 @default.
• W4229072237 crossrefType "journal-article" @default.
• W4229072237 hasAuthorship W4229072237A5006474475 @default.
• W4229072237 hasAuthorship W4229072237A5021824454 @default.
• W4229072237 hasAuthorship W4229072237A5028761825 @default.
• W4229072237 hasAuthorship W4229072237A5033535964 @default.
• W4229072237 hasAuthorship W4229072237A5045386706 @default.
• W4229072237 hasAuthorship W4229072237A5047671590 @default.
• W4229072237 hasAuthorship W4229072237A5051502371 @default.
• W4229072237 hasAuthorship W4229072237A5053008699 @default.
• W4229072237 hasAuthorship W4229072237A5053082544 @default.
• W4229072237 hasAuthorship W4229072237A5054391702 @default.
• W4229072237 hasAuthorship W4229072237A5056666751 @default.
• W4229072237 hasAuthorship W4229072237A5072499672 @default.
• W4229072237 hasAuthorship W4229072237A5081247269 @default.
• W4229072237 hasAuthorship W4229072237A5081598314 @default.
• W4229072237 hasAuthorship W4229072237A5083463868 @default.
• W4229072237 hasAuthorship W4229072237A5085628613 @default.
• W4229072237 hasBestOaLocation W42290722371 @default.
• W4229072237 hasConcept C108516343 @default.
• W4229072237 hasConcept C126322002 @default.
• W4229072237 hasConcept C141071460 @default.
• W4229072237 hasConcept C14184104 @default.
• W4229072237 hasConcept C142724271 @default.
• W4229072237 hasConcept C159110408 @default.
• W4229072237 hasConcept C168563851 @default.
• W4229072237 hasConcept C203014093 @default.
• W4229072237 hasConcept C203092338 @default.
• W4229072237 hasConcept C204787440 @default.
• W4229072237 hasConcept C207480886 @default.
• W4229072237 hasConcept C27081682 @default.
• W4229072237 hasConcept C2779951463 @default.
• W4229072237 hasConcept C2781390199 @default.
• W4229072237 hasConcept C3019717275 @default.
• W4229072237 hasConcept C44249647 @default.
• W4229072237 hasConcept C71924100 @default.
• W4229072237 hasConcept C90924648 @default.
• W4229072237 hasConceptScore W4229072237C108516343 @default.
• W4229072237 hasConceptScore W4229072237C126322002 @default.
• W4229072237 hasConceptScore W4229072237C141071460 @default.
• W4229072237 hasConceptScore W4229072237C14184104 @default.
• W4229072237 hasConceptScore W4229072237C142724271 @default.
• W4229072237 hasConceptScore W4229072237C159110408 @default.
• W4229072237 hasConceptScore W4229072237C168563851 @default.
• W4229072237 hasConceptScore W4229072237C203014093 @default.
• W4229072237 hasConceptScore W4229072237C203092338 @default.
• W4229072237 hasConceptScore W4229072237C204787440 @default.
• W4229072237 hasConceptScore W4229072237C207480886 @default.
• W4229072237 hasConceptScore W4229072237C27081682 @default.

• next